Prostate biopsy, a cornerstone of cancer diagnosis, involves the removal of tissue samples from the prostate gland to detect cancerous cells. Typically conducted when other tests, like PSA screening or digital rectal exams, suggest abnormalities, it's vital for accurate diagnosis and treatment planning. Utilizing imaging guidance, such as ultrasound, doctors precisely target suspicious areas for sampling, often using a needle to extract tissue. While effective, biopsies carry risks, including bleeding and infection, highlighting the need for careful patient monitoring post-procedure. Innovations like MRI-guided biopsies enhance accuracy, reducing unnecessary procedures and improving cancer detection rates. Moreover, ongoing research focuses on refining biopsy techniques, exploring biomarkers, and developing non-invasive alternatives, promising more precise and patient-friendly diagnostic approaches in the future.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States